Dongdong Wang

Dr. Dongdong Wang

Ghent University - Faculty of bioscience engineering - ARC lab
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 November 2020 in Journal of Natural Products
Verified
Journal Article
Closed access
UKUnwoo Kang
Unwoo Kang
LCLaura K. Cartner
Laura K. Cartner
Dongdong WangDongdong Wang
Dongdong Wang
CKChang-Kwon Kim
Chang-Kwon Kim
CTCheryl L. Thomas
Cheryl L. Thomas
Kirk GustafsonKirk Gustafson
Kirk Gustafson

13 December 2017 in Journal of Natural Products
Verified
Journal Article
Closed access
LRLuke P. Robertson
Luke P. Robertson
SDSandra Duffy
Sandra Duffy
Yun WangYun Wang
Yun Wang
Dongdong WangDongdong Wang
Dongdong Wang
VAVicky Avery
Vicky Avery
ACAnthony Carroll
Anthony Carroll

17 February 2016 in Journal of Natural Products
Verified
Journal Article
Open access
Dongdong WangDongdong Wang
Dongdong Wang
YFYunjiang Feng
Yunjiang Feng
MMMariyam Murtaza
Mariyam Murtaza
SWStephen Wood
Stephen Wood
GMGeorge D. Mellick
George D. Mellick
RQRonald J Quinn
Ronald J Quinn
A grand challenge in natural product chemistry is to determine the biological effects of all natural products. A phenotypic approach is frequently used for determining the activity of a compound and its potential impact on a disease state. Chemical investigation of a specimen of Jaspis splendens collected from the Great Barrier Reef resulted in the isolation of a new pterin derivative, jaspterin (1), a new bisindole alkaloid, splendamide (2), and a new imidazole alkaloid, jaspnin A (3) TFA salt. Jaspamycin (8) and 6-bromo-1H-indole-3-carboximidamide (16) are reported for the first time as naturally occurring metabolites. Known nucleosides (4–7, 9, 10), aglycones (11–13), indole alkaloids (14, 15, 17), and jaspamide peptides (18–22) were also isolated. The structures of the three new compounds 1–3 were unambiguously elucidated based on NMR and mass spectroscopic data. Jaspnin A (3) contained a rare thiomethylated imidazolinium unit. Coupling an unbiased phenotypic assay using a human olfactory neurosphere-derived cell model of Parkinson’s disease to all of the natural products from the species J. splendens allowed the phenotypic profiles of the metabolites to be investigated.

6 November 2015 in Aquaculture International
Verified
Journal Article
Closed access
PDF file
GYGang Yang
Gang Yang
Xiangli TianXiangli Tian
Xiangli Tian
SDShuanglin Dong
Shuanglin Dong
MPMo Peng
Mo Peng
DWDongdong Wang
Dongdong Wang
KZKai Zhang
Kai Zhang

26 October 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
DWDongdong Wang
Dongdong Wang
JLJiahui Li
Jiahui Li
GZGuoliang Zhu
Guoliang Zhu
KZKun Zhao
Kun Zhao
WJWenwen Jiang
Wenwen Jiang
Xiangli TianXiangli Tian
Xiangli Tian
The global shrimp industry has suffered bacterial diseases caused mainly by Vibrio species. The typical vibriosis, acute hepatopancreatic necrosis disease (AHPND), has resulted in mass mortality and devastating economic losses. Thus, therapeutic strategies are highly needed to decrease the risk of vibriosis outbreaks. Herein, we initially identified that the growth of the causative agent of AHPND, Vibrio parahaemolyticus (VPAHPND) and other vibrios in Pacific white shrimp (Litopenaeus vannamei) was inhibited by a Bacillus subtilis strain BSXE-1601. The natural products amicoumacins A, B, and C were purified from the cell-free supernatant from the strain BSXE-1601, but only amicoumacin A was demonstrated to be responsible for this anti-Vibrio activity. Our discovery provided the first evidence that amicoumacin A was highly active against shrimp pathogens, including the representative strain VPAHPND. Furthermore, we elucidated the amicoumacin A biosynthetic gene cluster by whole genome sequencing of the B. subtilis strain BSXE-1601. In addition to amicoumacin A, the strain BSXE-1601 genome harbored other genes encoding bacillibactin, fengycin, surfactin, bacilysin, and subtilosin A, all of which have previously reported antagonistic activities against pathogenic strains. The whole-genome analysis provided unequivocal evidence in support of the huge potential of the strain BSXE-1601 to produce diverse biologically antagonistic natural products, which may facilitate further studies on the effective therapeutics for detrimental diseases in shrimp.